Close

PRA Health Sciences (PRAH) Tops Q3 EPS by 6c, Offers FY Guidance

October 31, 2018 4:42 PM EDT

PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $1.13, $0.06 better than the analyst estimate of $1.07. Revenue for the quarter came in at $717.6 million versus the consensus estimate of $726.88 million.

GUIDANCE:

PRA Health Sciences sees FY2018 EPS of $4.22-$4.27, versus the consensus of $4.19. PRA Health Sciences sees FY2018 revenue of $2.87-2.92 billion, versus the consensus of $2.91 billion.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings